-
1
-
-
84874110062
-
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
-
C. Weiler-Normann, C. Schramm, A. Quaas, C. Wiegard, C. Glaubke, and N. Pannicke et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis J Hepatol 58 2013 529 534
-
(2013)
J Hepatol
, vol.58
, pp. 529-534
-
-
Weiler-Normann, C.1
Schramm, C.2
Quaas, A.3
Wiegard, C.4
Glaubke, C.5
Pannicke, N.6
-
3
-
-
72149112759
-
Autoimmune diseases induced by biological agents: A double-edged sword?
-
M. Ramos-Casals, A. Roberto Perez, C. Diaz-Lagares, M.J. Cuadrado, and M.A. Khamashta Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9 2010 188 193
-
(2010)
Autoimmun Rev
, vol.9
, pp. 188-193
-
-
Ramos-Casals, M.1
Roberto Perez, A.2
Diaz-Lagares, C.3
Cuadrado, M.J.4
Khamashta, M.A.5
-
4
-
-
84864276794
-
Autoimmune hepatitis induced by adalimumab with successful switch to abatacept
-
A. Grasland, R. Sterpu, S. Boussoukaya, and I. Mahe Autoimmune hepatitis induced by adalimumab with successful switch to abatacept Eur J Clin Pharmacol 68 2012 895 898
-
(2012)
Eur J Clin Pharmacol
, vol.68
, pp. 895-898
-
-
Grasland, A.1
Sterpu, R.2
Boussoukaya, S.3
Mahe, I.4
-
5
-
-
33847686821
-
Serious liver disease induced by infliximab
-
G.J. Tobon, C. Canas, J.J. Jaller, J.C. Restrepo, and J.M. Anaya Serious liver disease induced by infliximab Clin Rheumatol 26 2007 578 581
-
(2007)
Clin Rheumatol
, vol.26
, pp. 578-581
-
-
Tobon, G.J.1
Canas, C.2
Jaller, J.J.3
Restrepo, J.C.4
Anaya, J.M.5
-
6
-
-
82555194138
-
Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: The index case
-
D.A. Goldfeld, E.C. Verna, J. Lefkowitch, and A. Swaminath Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case Dig Dis Sci 56 2011 3386 3388
-
(2011)
Dig Dis Sci
, vol.56
, pp. 3386-3388
-
-
Goldfeld, D.A.1
Verna, E.C.2
Lefkowitch, J.3
Swaminath, A.4
-
7
-
-
34147109887
-
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
-
A.M. Garcia Aparicio, J.R. Rey, A.H. Sanz, and J.S. Alvarez Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab Clin Rheumatol 26 2007 811 813
-
(2007)
Clin Rheumatol
, vol.26
, pp. 811-813
-
-
Aparicio, A.M.G.1
Rey, J.R.2
Sanz, A.H.3
Alvarez, J.S.4
-
8
-
-
57049092892
-
Infliximab-induced hepatitis: Absence of cross-toxicity with etanercept
-
G. Thiefin, A. Morelet, A. Heurgue, M.D. Diebold, and J.P. Eschard Infliximab-induced hepatitis: absence of cross-toxicity with etanercept Joint Bone Spine 75 2008 737 739
-
(2008)
Joint Bone Spine
, vol.75
, pp. 737-739
-
-
Thiefin, G.1
Morelet, A.2
Heurgue, A.3
Diebold, M.D.4
Eschard, J.P.5
-
9
-
-
69549117354
-
Drug-induced autoimmunity
-
F. Dedeoglu Drug-induced autoimmunity Curr Opin Rheumatol 21 2009 547 551
-
(2009)
Curr Opin Rheumatol
, vol.21
, pp. 547-551
-
-
Dedeoglu, F.1
-
10
-
-
0036694562
-
Role of TNF/TNFR in autoimmunity: Specific TNF receptor blockade may be advantageous to anti-TNF treatment
-
G. Kollias, and D. Kontoyiannis Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatment Cytokine Growth Fact Rev 13 2002 315 321
-
(2002)
Cytokine Growth Fact Rev
, vol.13
, pp. 315-321
-
-
Kollias, G.1
Kontoyiannis, D.2
-
11
-
-
80052680230
-
Contrasting effects of TNF and anti-TNF on activation of effector T cells and regulatory T cells in autoimmunity
-
X. Chen, and J.J. Oppenheim Contrasting effects of TNF and anti-TNF on activation of effector T cells and regulatory T cells in autoimmunity FEBS Lett 585 2011 3611 3618
-
(2011)
FEBS Lett
, vol.585
, pp. 3611-3618
-
-
Chen, X.1
Oppenheim, J.J.2
|